Oragenics (OGEN)
(Delayed Data from AMEX)
$1.27 USD
+0.25 (24.51%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $1.28 +0.01 (0.79%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.27 USD
+0.25 (24.51%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $1.28 +0.01 (0.79%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Company News for Aug 31, 2021
by Zacks Equity Research
Companies in the news are: DSPG, IDEX, OGEN, AFRM
Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3
by Zacks Equity Research
Intrexon (XON) incurs narrower-than-expected loss, while revenues miss estimates in the third quarter of 2018.
Intrexon (XON) Q4 Loss Wider than Expected, Revenues Lag
by Zacks Equity Research
Intrexon reported adjusted loss per share of 26 cents in the fourth quarter of 2016 wider than the Zacks Consensus Estimate loss of 23 cents.